PMID: 9192060Mar 1, 1997Paper

The natural history of ulcerative colitis

Baillière's Clinical Gastroenterology
W Selby

Abstract

The majority of patients with ulcerative colitis (UC) will run a typical chronic, relapsing course. The proportion with chronic, continuous symptoms diminishes with time. The greatest impact of the disease is in the first few years after diagnosis, especially in patients with extensive or severe colitis. After this time, the likelihood of requiring surgery declines rapidly, and survival is no different from that of the general population. The long-term course can be best predicted by the course in the preceding period. Most patients are able to lead an essentially normal lifestyle, at work and at home, with either medical or surgical treatment. Awareness of how the patient feels the disease affects his or her life is important. Educating the patient about their illness will also help in management.

References

May 27, 1978·Lancet·J K RitchieJ E Lennard-Jones
Sep 16, 1978·Lancet·S J MallettE Gilon
Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
Dec 1, 1991·Scandinavian Journal of Gastroenterology·E LangholzV Binder
Nov 1, 1990·The New England Journal of Medicine·A EkbomH O Adami
Jun 1, 1988·Journal of Clinical Gastroenterology·A MitchellF Wagner
Jun 1, 1988·Scandinavian Journal of Gastroenterology·K HaugJ F Halvorsen
Apr 1, 1987·Gut·C M StonningtonA R Zinsmeister
Oct 1, 1987·Gut·C M StonningtonL J Melton
Oct 1, 1987·Scandinavian Journal of Gastroenterology·O BroströmG Hellers
Aug 30, 1980·British Medical Journal·C Hendriksen, V Binder
Aug 1, 1995·Annals of Surgery·V W FazioT K Schroeder
Mar 1, 1995·Diseases of the Colon and Rectum·B DamgaardP Kirkegaard
Mar 1, 1995·Digestive Diseases and Sciences·A ScalziniL Sueri
Jan 1, 1993·Journal of Gastroenterology and Hepatology·W Selby
Jun 30, 1994·The New England Journal of Medicine·S LichtigerS Hanauer
Mar 1, 1993·Digestive Diseases and Sciences·C S ProbertJ F Mayberry
Jan 1, 1995·Scandinavian Journal of Gastroenterology. Supplement·G M Houben, R W Stockbrügger
Dec 1, 1963·Gut·F C EDWARDS, S C TRUELOVE

❮ Previous
Next ❯

Citations

Jun 18, 1999·Gastroenterology Clinics of North America·P G Andres, L S Friedman
Mar 3, 2005·Journal of Gastroenterology and Hepatology·Alireza MoayyeriMohsen Sadatsafavi
Oct 7, 2008·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G BresciA Capria
Apr 15, 2008·World Journal of Gastroenterology : WJG·Takafumi AndoHidemi Goto
Aug 10, 2012·World Journal of Gastroenterology : WJG·Giovanni Latella, Claudio Papi
Sep 9, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·James AllisonJames Lowder
Jun 26, 1999·Gastroenterology·M A KemlerM Van Kleef
Jun 3, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Walter ReinischPeter D R Higgins
Oct 14, 2009·Inflammatory Bowel Diseases·Francisco PortelaA Costa-Pereira
Jul 13, 2013·Inflammatory Bowel Diseases·Alastair WindsorSubrata Ghosh
Jul 28, 2011·Inflammatory Bowel Diseases·Fernando MagroElizabeth Benito Garcia
Sep 26, 2008·Inflammatory Bowel Diseases·Kevin Rioux
May 7, 2004·Journal of Clinical Gastroenterology·Esmeralda C Marginean, Dhanpat Jain
Dec 22, 2010·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·You Suk OhGyu Yong Choi
Jun 9, 2007·The American Journal of Gastroenterology·Ole HöieUNKNOWN European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD)
Apr 17, 2008·European Journal of Immunology·Teruji TotsukaMamoru Watanabe
Apr 18, 2019·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Keisuke KawasakiTakayuki Matsumoto
Aug 12, 2014·World Journal of Gastroenterology : WJG·Abbi R SaniabadiHiroyuki Hanai
Aug 28, 2014·Expert Review of Gastroenterology & Hepatology·Rodolfo SaccoAbbi R Saniabadi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.